BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and its prognosis prediction is still challenging. Even with the mounting researches on the mechanisms of tumor immunotherapy, the prognostic value of T-cell proliferation regulators in bladder cancer remains elusive.MethodsHerein, we collected mRNA expression profiles and relevant clinical information of bladder cancer sufferers from a publicly available data base. Then, the LASSO Cox regression model was utilized to establish a multi-gene signature for the TCGA cohort to predict the prognosis and staging of bladder cancer. Eventually, the predictive power of the model was validated by randomized grouping.ResultsThe outcomes revealed that most ge...
Background: Bladder cancer (BLCA) ranks 10th in incidence among malignant tumors and 6th in incidenc...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...
BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and i...
BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and i...
BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and i...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Background: Immune checkpoint inhibitor therapy has changed the treatment model of metastatic bladde...
Background: Immune checkpoint inhibitor therapy has changed the treatment model of metastatic bladde...
Purpose. The complex etiological variables and high heterogeneity of bladder cancer (BC) make progno...
BackgroundBladder cancer is a common malignant type in the world, and over 90% are transitional cell...
Background: Bladder cancer (BLCA) ranks 10th in incidence among malignant tumors and 6th in incidenc...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...
BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and i...
BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and i...
BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and i...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a ...
Background: Immune checkpoint inhibitor therapy has changed the treatment model of metastatic bladde...
Background: Immune checkpoint inhibitor therapy has changed the treatment model of metastatic bladde...
Purpose. The complex etiological variables and high heterogeneity of bladder cancer (BC) make progno...
BackgroundBladder cancer is a common malignant type in the world, and over 90% are transitional cell...
Background: Bladder cancer (BLCA) ranks 10th in incidence among malignant tumors and 6th in incidenc...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...